A
Assyl Arykbayeva Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
grad_student
1 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Assyl Arykbayeva, a graduate student at the University of Central Arkansas, focuses on Leishmaniasis studies, synthesis, and biological activity. Her research also encompasses bioactive compounds and antitumor agents. Arykbayeva's recent work was published in 2024.
Metrics
- Publications: 1
Selected Publications
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
Collaboration Network
Top Collaborators
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gabriel Gifford
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Eva R. Palmer
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alex Rogers
University of Central Arkansas (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Emily N. H. Tran
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Lucy Fry
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alexx Weaver
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Anne K. Bowlin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Meghan D. Jones
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Michael R. Eledge
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Karl W. Boehme
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gregory R. Naumiec
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Tiffany Weinkopff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs